Home-based telerehabilitation versus center-based pulmonary rehabilitation for COPD

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Adults referred for pulmonary rehabilitation who meet eligibility criteria are enrolled and assigned to either a home-based telerehabilitation program using telehealth technologies or a standard center-based pulmonary rehabilitation program. The programs deliver supervised exercise training and standard pulmonary rehab components, and patients complete baseline and post-program measures. The primary outcome is change in exercise endurance time before and after the rehabilitation program. The trial targets patients with GOLD stage II–IV COPD who are clinically stable and able to participate safely in exercise.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Age between 45 and 80 years
* Confirmed diagnosis of chronic obstructive pulmonary disease, GOLD stage II to IV
* Stable condition (no exacerbation in the last month prior to participation)
* Referred to a pulmonary rehabilitation program
* With or without oxygen during exercise
* No pulmonary rehabilitation program in the last 12 months prior to participation
* Living at home with another adult present during exercise sessions
* Affiliated with a health insurance system
* Able to read and understand the information letter and sign the consent form

Non-inclusion criteria:

* Referred to pulmonary rehabilitation before lung cancer surgery
* Referred to pulmonary rehabilitation before lung volume reduction surgery scheduled within the next four months
* Visual, cognitive, or auditory impairments incompatible with participation in a tele-pulmonary rehabilitation program
* Orthopedic, neurological, cardiovascular, or neuromuscular conditions limiting exercise training on a cycle ergometer
* Active cancer
* Unable to provide informed consent
* Under legal guardianship or curatorship
* Pregnant or breastfeeding women

Exclusion Criterion:

* Withdrawal of consent

Where it's running

• Association ADIR
  Rouen, France Recruiting
• Groupe Hospitalier du Havre
  Montivilliers, France Not yet recruiting
• Centre Hospitalier des Pays de Morlaix
  Morlaix, France Not yet recruiting
• Hôpital La Musse
  Saint-Sébastien-de-Morsent, France Not yet recruiting

Study contacts

• Principal investigator: Tristan Bonnevie, PhD — Association ADIR
• Study coordinator: Tristan Bonnevie, PhD
• Email: t.bonnevie@adir-hautenormandie.com
• Phone: 0235592970

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Chronic Respiratory Disease Participant Engagement

  This study tests whether adults with long-term lung conditions can get comfortable with a clinical trials unit and research team before joining future trials.

  Recruiting Richmond Pharmacology Limited · London · NCT07924462

• IOS-based platform to screen, diagnose, and manage COPD and asthma

  This study tests an Impulse Oscillometry system to screen for and diagnose COPD and asthma and to help predict flare-ups over about a year, involving adults in China.

  Recruiting Beijing Chao Yang Hospital · Beijing, Beijing Municipality · NCT07910409

• Targeted NMES to improve breathing and leg/extra muscle strength in COPD

  This study tests whether targeted neuromuscular electrical stimulation helps people with COPD see improvements in breathing muscle function and overall muscle strength.

  Recruiting Universitas Padjadjaran · Bandung, West Java · NCT07910006

• AERO-007: a inhaled LABA+LAMA combination for COPD through a nebulizer

  This study tests whether a nebulized LABA+LAMA combination can improve lung function in adults with COPD.

  Recruiting Phase 2 AeroRx Therapeutics Inc. · London and 1 other locations · NCT07896252

• PBMT with a pulmonary rehab program for COPD patients

  A small randomized trial tests whether adding photobiomodulation therapy before exercise in a COPD pulmonary rehab program helps improve functional capacity.

  Recruiting Federal University of Health Science of Porto Alegre · Porto Alegre, Rio Grande do Sul · NCT07878884

• Controlled versus standard oxygen therapy for ICU COPD with acute exacerbation

  This trial tests whether keeping oxygen levels at 88-92% helps ICU patients with an acute COPD flare more than keeping levels above 94%.

  Recruiting Hôpital Universitaire Taher Sfar · Mahdia, Mahdia Governorate and 1 other locations · NCT07842510

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.